In the grip of the python: Conflicts at the university-industry interface

Science and Engineering Ethics

Volumn 9, Issue 1, 2003, Pages 59-71

  Healy, David ^a,b  

^a BANGOR UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Academic freedom; Ghostwriting; Hazards of drug treatment

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

DRUG INDUSTRY; ETHICS; HUMAN; LEGAL ASPECT; REVIEW; SUICIDAL BEHAVIOR; SUICIDE; UNIVERSITY; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CANADA; CONFLICT OF INTEREST; FREEDOM; INSTITUTIONAL ETHICS; INTERPERSONAL COMMUNICATION; ORGANIZATION AND MANAGEMENT; PSYCHOLOGICAL ASPECT; PUBLIC RELATIONS; RESEARCH ETHICS; SCIENTIFIC MISCONDUCT; SMITHKLINE BEECHAM; UNIVERSITY OF TORONTO;

BIOMEDICAL AND BEHAVIORAL RESEARCH; SMITHKLINE BEECHAM; UNIVERSITY OF TORONTO;

CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; ETHICS, INSTITUTIONAL; ETHICS, RESEARCH; FREEDOM; HUMANS; INTERINSTITUTIONAL RELATIONS; ONTARIO; SCIENTIFIC MISCONDUCT; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNIVERSITIES;

EID: 0037256327     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-003-0020-2     Document Type: Review

References (44)

1. Thompson, J., Baird, P., Downie, J. (2001). The Olivieri Report, James Lorimer & Co., Toronto.
2. Angell, M. (2000). Is academic medicine for sale? New England Journal of Medicine 342: 1516-1518.
3. Lewis, S., Baird, P., Evans, R.G., Ghalli, W., Wright, C.J., Gibson, E., Bayliss, F. (2001) Dancing with the Porcupine. Rules for governing the university-industry relationship, Canadian Medical Assoc. Journal 165: 783-785.
4. Teicher, M.H., Glod, C., Cole, J.O. (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment, Am J Psychiatry 147: 207-210.
5. Creaney, W., Murray, I. and Healy, D. (1991) Antidepressant induced suicidal ideation, Human Psychopharmacology 6: 329-332
6. Healy, D. (1994) The fluoxetine and suicide controversy, CNS Drugs 1: 223-231
7. Cornwell, J. (1996) The Power to Harm, Viking Penguin, New York.
8. Cole, J. O. (1999) Affidavit in Miller vs Pfizer.
9. th.
10. Oswald, I. (2000) The Halcion Affair. The Psychopharmacologists Volume 3, Arnold, London.
11. Tobin versus SmithKline Beecham. Case No. 00-CV-0025-BEA.
12. Healy, D. (1997) The Antidepressant Era, Harvard University Press, Cambridge MA, USA.
13. Tranter, R., Healy, H., Cattell, D. and Healy, D. (2002) Functional effects of agents differentially selective to noradrenergic or serotonergic systems, Psychological Medicine 32: 517-524.
14. Healy, D. (2000) Antidepressant induced suicidality, Primary Care Psychiatry 6: 23-28.
15. Healy, D. (2002) The Creation of Psychopharmacology, Harvard University Press, Cambridge MA. USA.
16. Thase, M.E., Entsuah, A.R. and Rudolph, R.L. (2001) Remission rates during treatment with venlafaxine and selective serotonin reuptake inhibitors, British Journal of Psychiatry 178, 234-141
17. Wright, I.C. (2002) Conflict of interest and the British Jounal of Psychiatry, British Journal of Psychiatry 180, 82-83
18. Editorial (2002) Just how tainted has medicine become? Lancet 359: 1167-1168.
19. Healy, D., Savage, M., Michael, P., Harris, M., Hirst, D. Carter, M., Cattell, D., McMonagle, T., Sohler, N. and Susser, E. (2001) Psychiatric bed utilisation: 1896 and 1996 compared, Psychological Medicine 31, 779-790
20. Healy, D. (2000) Good Science or Good Business? Hastings Center Report 30: 19-22.
21. Elliott, C. (2000) Pursued by Happiness and Beaten Senseless, Hastings Center Report 30: 7-12.
22. Kramer, P. (2000) The valorisation of sadness, Hastings Center Report 30: 13-18.
23. DeGrazia, D. (2000) Prozac, enhancement and self-creation, Hastings Center Report 30: 34-40.
24. Edwards, J.C. (2000) Passion, activity and "The Care of the Self", Hastings Center Report 30: 31-33.
25. Healy, D. (1999) Guest Editorial: A Failure to Warn, Int J Risk & Safety in Medicine 12: 151-156.
26. Healy, D. (1999) The Three Faces of the Antidepressants. Critical Comments on the Clinical-Economic Framework of Diagnosis, Journal of Nervous & Mental Disease 187: 174-180
27. Healy, D., Langmaak, C. and Savage, M. (1999) Suicide in the Course of the Treatment of Depression, Journal of Psychopharmacology 13: 94-99.
28. Tranter, R, C. O'Donovan, Chandarana, P, and S. Kennedy (2002) Prevalence and outcome of partial remission in depression, Journal of Psychiatry and Clinical Neuroscience 27: 241-247.
29. nd 2001.
30. Khan, A, Warner, H.A. and Brown, W.A. (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials, Archives of General Psychiatry 57: 311-317.
31. th 1991.
32. st 1991.
33. Healy, D. (2003). Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors. Psychotherapy and Psychosomatics. (Scheduled for publication March 2003.
34. Lopez-Ibor, J.J. (1993) Reduced suicidality on paroxetine, European Psychiatry 1 (Suppl 8): 17s-19s.
35. Montgomery, S.A., Dunner, D.L., Dunbar, G. (1995) Reduction of suicidal thoughts with paroxetine in comparison to reference antidepressants and placebo, European Neuropsychopharmacology 5: 5-13.
36. Davidoff, F., DeAngelis, C.D., Drazen, J.M., et al (2001) Sponsorship, authorship, and accountability, New England Journal of Medicine 345: 825-827.
37. Healy, D. (in press). Is academic psychiatry for sale? British Journal of Psychiatry.
38. Schafer, A. (October 2001) Medicine, morals and money. Dancing with porcupines or sleeping beside elephants. Doctors for research Integrity Meeting, Hart House, Toronto.
39. Lewis, S., Baird, P., Evans, R.G., Ghalli, W., Wright, C.J., Gibson, E., Bayliss, F. (2001) Dancing with the Porcupine. Rules for governing the university-industry relationship. Canadian Medical Assoc. Journal 165: 783-785.
40. Healy, D. (2001) When Interests Conflict. Pharmaceutical Executive, August p. 98.
41. Stecklow S, Johannes L. (1997) "Questions arise on new drug testing. Drug makers relied on clinical researchers who now await trial," Wall Street Journal, August 15th
42. Eichenwald K, Kolata G. (1999) "Drug trials hide conflict for doctors," New York Times, May 16th pages, 1, 28, 29; and "A doctor's drug studies turn into fraud," New York Times, May 17th pages 1, 16, 17.
43. Boseley S. (1999) "Trial and error puts patients at risk," Guardian (London) July 27th, p 8.
44. Healy D. (2003/in press). Let them Eat Prozac, Lorimer, Toronto.